{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:59:00Z","timestamp":1790459940013,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40264-018-0683-x","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T01:21:23Z","timestamp":1526865683000},"page":"951-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice"],"prefix":"10.1007","volume":"41","author":[{"given":"Jim","family":"Slattery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"683_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","volume":"49","author":"K Andersson","year":"1994","unstructured":"Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized clinical trial. Contraception. 1994;49:56\u201372.","journal-title":"Contraception."},{"issue":"10","key":"683_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/09513590903159656","volume":"25","author":"A Ayman","year":"2009","unstructured":"Ayman A, Ewies A. Levonorgestrel-releasing intrauterine system: the discontinuing story. Gynecol Endocrinol. 2009;25(10):668\u201373.","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"683_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/09513590802444167","volume":"24","author":"S Daud","year":"2008","unstructured":"Daud S, Ewies A. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecol Endocrinol. 2008;24(12):686\u201390.","journal-title":"Gynecol Endocrinol"},{"key":"683_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1471-0528.2007.01306.x","volume":"114","author":"K Halmesm\u00e4ki","year":"2007","unstructured":"Halmesm\u00e4ki K, Hurskainen R, Teperi J, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning in women with menorrhagia: a 5\u00a0year randomized controlled trial. BJOG. 2007;114:563\u20138.","journal-title":"BJOG"},{"key":"683_CR5","unstructured":"Patient Info. Anxiety and Mirena\u00ae (IUD). https:\/\/patient.info\/forums\/discuss\/anxiety-and-mirena-iud\u2013587345 . Accessed 4 Apr 2018."},{"key":"683_CR6","unstructured":"FBDC. Mirena\u00ae ruined my life: a public service announcement. https:\/\/fueledbydietcoke.com\/2012\/12\/10\/mirena-iud-ruined-my-life-a-public-service-announcement\/ . Accessed 4 Apr 2018."},{"key":"683_CR7","unstructured":"Akd\u00c4. Psychiatrische Erkrankungen als unerw\u00fcnschte Arzneimittelwirkung von Mirena\u00ae (Aus der UAW-Datenbank). https:\/\/www.akdae.de\/Arzneimittelsicherheit\/Bekanntgaben\/Archiv\/2009\/20090501.html . Accessed 4 Apr 2018."},{"key":"683_CR8","first-page":"171","volume":"12","author":"A Bourke","year":"2004","unstructured":"Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171\u20137.","journal-title":"Inform Prim Care."},{"key":"683_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pds.1688","volume":"18","author":"A Maguire","year":"2009","unstructured":"Maguire A, Blak B, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18:76\u201383.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"683_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/13625187.2013.852170","volume":"19","author":"LC Soriano","year":"2013","unstructured":"Soriano LC, Wallander MA, Andersson SW, Requena G, Garc\u00eda-Rodr\u00edguez LA. Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology. Eur J Contracept Reprod Health Care. 2013;19(1):22\u20138.","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"3","key":"683_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2532.1994.1130177.x","volume":"11","author":"N Booth","year":"1994","unstructured":"Booth N. What are the Read Codes? Health Libr Rev. 1994;11(3):177\u201382.","journal-title":"Health Libr Rev."},{"key":"683_CR12","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall; 1984."},{"issue":"3","key":"683_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.31887\/DCNS.2008.10.3\/dnutt","volume":"10","author":"D Nutt","year":"2008","unstructured":"Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10(3):329\u201336.","journal-title":"Dialogues Clin Neurosci."},{"key":"683_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2018.01.010","author":"B Worly","year":"2018","unstructured":"Worly B, Gur T, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception. 2018. https:\/\/doi.org\/10.1016\/j.contraception.2018.01.010 (Epub ahead of print).","journal-title":"Contraception."},{"key":"683_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","volume":"73","author":"CW Skovlund","year":"2016","unstructured":"Skovlund CW, M\u00f8rch LS, Kessing LV, Lidegaard \u00d8. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73:1154\u201362.","journal-title":"JAMA Psychiatry."},{"key":"683_CR16","volume-title":"Sexual and reproductive health services, England 2015\u201316","author":"Office of National Statistics","year":"2016","unstructured":"Office of National Statistics. Sexual and reproductive health services, England 2015\u201316. London: Office of National Statistics; 2016."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-018-0683-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T19:04:42Z","timestamp":1661281482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-018-0683-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1007\/s40264-018-0683-x","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"21 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical standards"}},{"value":"This study was conducted using European Medicines Agency resources and no additional funding source.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jim Slattery, Daniel Morales, Luis Pinheiro and Xavier Kurz have no direct or indirect financial or personal interest in the products included in this study or in competitor products.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study uses de-identified data from UK general practice collected in the THIN database.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The study protocol was approved by the THIN Scientific Review Committee.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The views expressed in this article are those of the authors and should not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}